Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | FASN | P49327 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19613156 | 1.00 | CNR1 (0.46) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL317505 | 1.00 | CNR1 (0.46) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL19612862 | 1.00 | CNR1 (0.46) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL19612860 | 1.00 | CNR1 (0.46) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL317504 | 1.00 | CNR1 (0.46) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL19613188 | 0.90 | CNR1 (0.47) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL19612868 | 0.90 | CNR1 (0.47) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL19612869 | 0.90 | CNR1 (0.47) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL317399 | 0.90 | CNR1 (0.47) | CNR1CNR2KDM4EFASNALDH1A1 | |
| SCHEMBL317400 | 0.90 | CNR1 (0.47) | CNR1CNR2KDM4EFASNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180280337-A1 | NUTRITIONAL COMPOSITIONS COMPRISING SN-1(3) MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF GROWTH DELAY IN INFANTS OR CHILDREN | Société des Produits Nestlé S.A. (CH) | 2018-10-04 | — | — | US | disclosed |
| US-20170332691-A1 | NUTRITIONAL COMPOSITIONS COMPRISING SN-1 (3) MONOACYLGLYCEROLS FOR USE IN THE TREATMENT OF MALABSORPTION OR MALDIGESTION IN INFANTS OR YOUNG CHILDREN | Société des Produits Nestlé S.A. (CH) | 2017-11-23 | — | — | US | disclosed |